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Influence of chronic cerebrospinal venous
insufficiency on demyelinating diseases
Abstract
We analyzed all the arguments against chronic cerebrospinal venous ins-
ufficiency (CCSVI) as a medical entity, and its association with a disabling
demyelinating disease, multiple sclerosis (MS). We revised all the findings
suggesting a possible connection between these two entities. By comparing
the results obtained by different study groups, we noted a great variability in
prevalence of CCSVI in MS patients, ranging from 0 to 100%. Overall the
reported prevalence is respectively 70% in MS vs. 10% in controls, and a
recent meta-analysis assessed an over 13 times increased prevalence in MS.
Postmortem studies show a higher prevalence of intraluminal defects in the
main cerebral extracranial vein in MS patients respect to controls. Several
pathophysiological studies demonstrate correlation between CCSVI and
neglected vascular aspects of MS. Particularly, global hypo-perfusion of the
brain, as well as reduced cerebral spinal fluid dynamics in MS was shown to
be related to CCSVI. After careful review of all obtained data we can
conclude that great variability in prevalence of CCSVI in MS patients can
be a result of different methodologies used in vein assessment, training,
application of unapproved diagnostic criteria, or different approach to the
problem itself. By many studies it has been shown that CCSVI can be
inserted in the list of multiple factors involved in pathogenesis of MS, as well
as other neurodegenerative diseases.
Chronic cerebrospinal venous insufficiency (CCSVI) can be consi-dered one of the multiple factors involved in the pathogenesis of
demyelinating diseases, primarily multiple sclerosis (MS). It is a syn-
drome characterized by stenoses or obstructions of the internal jugular
(IJ) and/or azygos (AZ) veins with disturbed flow and formation of
collateral venous channels (1, 2). Venous narrowing are primary ob-
structions, mainly related to segmental hypoplasia or, more frequently,
to intraluminal defects like webs, fixed valve leaflets, membrane, in-
verted valve orientation, etc. (3, 4, 5).
The basis and foundation of venous anomalies are not entirely clear
yet. Venous lesions are described as truncular venous malformations,
presenting as intraluminal defects or segmental hypoplasia (6, 7, 8).
Developmental arrest in advanced stages of vascular trunk formation
during fetal life can result in such truncular venous malformations. Such
lesions are: aplasia, hypoplasia or hyperplasia of the vessel, a defective
vessel with obstruction from intraluminal lesions (e.g., vein web, spur,
annulus, or septum) or dilatation (e.g., jugular vein ectasia/aneurysm).
PAOLO ZAMBONI1
SANDRA MOROVI]2
1 Vascular Diseases Center
University of Ferrara, Italy
2 Department of Neurology
Polyclinic Centre Aviva
Nemetova 2, Zagreb, Croatia
Correspondence:
Professor Paolo Zamboni, MD
Vascular Diseases Center
University of Ferrara, Sant’Anna Hospital
Co. Giovecca 203, 44100 Ferrara, Italy
E-mail address: zmp@unife.it
Key words: Chronic Cerebrospinal Venous
Insufficiency, Demyelinating Diseases,
Multiple Sclerosis, Etiology Of Multiple
Sclerosis, Venous Anomalies, Intraluminal
Defects.
Received October 11, 2012.
PERIODICUMBIOLOGORUM UDC 57:61
VOL. 114, No 3, 387–392, 2012 CODEN PDBIAD
ISSN 0031- 5362
Overview
Radiological studies of healthy subjects did not demon-
strate these types of lesions (9–18), while CCSVI-like le-
sions were described associated to myelopathies (19, 20).
However, there are many publications pointing against
the existence and the association of CCSVI in MS. Ba-
gert et al. (21) state that investigations did not succeed in
verifying the relationship between CCSVI and MS and
they question the existence of CCSVI. Khan et al. (22)
stated that endovascular procedures in MS were »research
endeavors«, and that endovascular procedures should be
discouraged. A Canadian group (23) concluded that »the
performance of an interventional venous angioplasty …
is not appropriate at this time«. Reekers et al.’s (24)
randomized trials did not show a difference in the preva-
lence of venous stenosis between groups of patients with
or without MS. But a recent meta-analysis done by Lau-
pacis et al. (25) showed a positive association between
CCSVI and MS, with an increased risk of more than 13
times.
The aim of this Motion is to analyze all the arguments
against CCSVI as a medical entity and a subset of MS. In
addition, we revise all the findings suggesting a possible
connection between these two entities.
In the growing field of publications trying to demon-
strate either positive or negative association of CCSVI
with MS we will discuss the results of studies published
so far. These studies show very variable results which we
aim to comment. We observed grouping of results into
two main groups; those with a CCSVI prevalence higher
than 60%, from 60%–100% (1–3, 5, 26–27), and those
with absence of such lesions (28, 29), or CCSVI pre-
valence under 60% (30, 31) (Table 1)(Figure 1). This
variability could be the result of differences in technique,
training, experience or criteria used (32, 33).
Moreover, a recent meta-analysis done by Laupacis et
al. (25) showed a positive association between CCSVI
and MS. A systematic review and meta-analysis of all
reports from 2005 till June 2011 was performed, com-
paring the frequency of CCSVI and MS. Their findings
proved a significant association between CCSVI and MS
even after exclusion of the first study by Zamboni, the
meta-analysis was repeated after inclusion of Doepp’s
study, in which none of the patients or controls had
CCSVI, which also showed similar results. Despite this,
a strong association between CCSVI and MS was con-
cluded (OR 3.5, 95% 0.8–15.8).
But, are the studies in opposition really so opposite?
Doepp and al. reported no CCSVI in MS patients (34),
but their results did show a significant reduction of ve-
nous outflow in MS patients when their position changed
from supine to upright, which points towards a disturbed
venous outflow4. Doepp et al. (34) demonstrate a much
larger change in blood flow volume in normals com-
pared to MS patients when the subjects go from a supine
to upright position. They find a change of 128 ml/min
and 56 ml/min for the right and left sides respectively for
MS patients. But they found a much larger change of 266
ml/min and 105 ml/min for their normal subjects. This
result actually suggests the presence of CCSVI proven
with a different protocol. The causes of reduced outflow
changing posture to upright can be from intraluminal
septum, membrane, immobile valve affecting the hydro-
static pressure gradient. The presence of such blockages
in the extracranial and extravertebral cerebral veins have
been proven by using catheter venography (1, 35–38).
More interestingly, Diaconu et al. communicated at
ECTRIMS (European Committee for Treatment and
Research in Multiple Sclerosis) the results of a post-
-mortem study clearly showing a highest prevalence of
jugular septimentation with possible hemodynamic con-
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TABLE1
Prevalence of CCSVI in patients with MS and healthy
controls.
Author (ref) MS Patients Controls
CCSVI Total CCSVI
Zamboni et al, 2009 1 65(100%) 65 0(0%)
Zivadinov et al, 2011 42 162(56.1%) 289 374(22,7%)
Doepp et al, 2011 34 0(0%) 56 0(0%)
Mayer et al, 2011 28 0(0%) 20 1(5%)
Yamout et al, 2010 70 19(45%) 42 –
Baracchini et al, 2011 30 8(16%) 50 1(2%)
Al Omari et al, 2010 5 21(84%) 25 0(0%)
Simka et al, 2010 27 64(91%) 70 –
Bastianello et al, 201126 610(86%) 710 –
*Marder et al, 2011 29 0(0%) 18 –
Centonce et al, 201171 42(50%) 84 20(36%)
Zamboni et al, 2010 72 18(100%) 18 6(0%)
Zaharchuck et al, 201173 21(54%) 39 –
Zivadinov et al, 20113 10(100%) 10 –
Krogias et al, 2010 74 2(20%) 10 0(0%)
*18 controls with migraine or no neurological disease.
*18 control subjects with migraine or no neurological disease.
Figure 1. Meta-analysis of CCSVI prevalence in different studies.
sequences in MS patients respect to controls (39). This
result is confirmed by another autoptic study (40). Barac-
chini et al. reported 16% of CCSVI in MS patients at
disease onset, compared to 2% of CCSVI in healthy
controls (30). This finding suggests that CCSVI repre-
sents a nine times higher risk factor for disease onset,
showing increased susceptibility to MS in CCSVI sub-
jects (41). Zivadinov et al. recently reported CCSVI more
likely to be a secondary phenomenon to MS (42). Their
results showed that CCSVI was found in 50% of pedia-
tric MS cases as well as in 38% of CIS cases, thus making
the conclusion rash (43).
A well-established explanation for this great varia-
bility is the amount of training and experience investi-
gators have in echo-colour Doppler imaging. Studies
show (32, 42) that inter-operator variability decreases
post-training (from k=0.47 to k=0.80) while intra-ope-
rator reproducibility in trained operators was k=0.75.
Apart from this, ultrasound imaging still remains an
operator-dependent investigation.
Despite all, in more than 2000 investigated subjects,
the prevalence of CCSVI was 70% in MS patients com-
pared to prevalence of 10% in healthy controls. Studies
claiming to be in opposition to CCSVI still show dif-
ferent elements of abnormality of venous outflow in MS
patients compared to their healthy controls.
A positive connection between CCSVI and MS is
suggested by studies which tend to prove the presence of
cerebral hypoperfusion in MS patients. MR studies in
MS patients show a decrease in cerebral perfusion, af-
fecting widespread areas including normal-appearing
white matter (NAWM) (44).
A factor promoting development of ischemic brain
lesions in individuals with MS is globally decreased cere-
bral perfusion. A decrease in cerebral blood flow in both
gray and white matter was shown by SPECT (single-
-photon emission computed tomography) and PET (po-
sitron emission-computed tomography) studies. A study
using dynamic susceptibility contrast-enhanced MRI
(DSC-MRI) showed significantly decreased cerebral
blood flow (CBF) and prolonged mean transit time
throughout the NAWM of the brain in MS patients,
compared to controls (45). A study of regional pattern of
perfusion in NAWM reported a substantially decreased
cerebral blood flow (CBF) and cerebral blood volume
(CBV) in all NAWM regions in MS patients regardless of
disease form (46). Several reports claim hypoperfusion in
the cerebral cortex and subcortical gray matter of patients
with MS (47–50). This was proven by Varga et al. (51)
using DSC-MRI to assess CBF in cerebral NAWM,
thalamus, and putamen in MS patients and controls.
CBF was decreased in NAWM of patients with CIS and
RRMS, but not in healthy controls, suggesting a CBF
decrease of NAWM in early stages of disease. The hypo-
perfusion is believed to start in NAWM and it progresses
into the gray matter. So definitely, hypoperfusion is part
of MS.
Several mechanisms try to explain cerebral hypoper-
fusion (52, 53). However, among the theories trying to
explain diffuse and global hypoperfusion of brain paren-
chyma, CCSVI is the only finding explaining why CBF
is reduced at any point of the microcirculatory network,
in consequence of the disturbed outflow in the main
venous outflow route (44). This is confirmed by a study
showing a robust correlation between the number of
extracranial venous flow abnormalities detected by ultra-
sound and the severity of reduced CBF measured in the
brain microcirculation (54). In contrast, the other theo-
ries trying to explain global brain hypoperfusion fail to
clarify why the flow is reduced either in NAWM and in
NAGM (normal-appearing gray matter). Moreover, re-
duced CBF means stasis, highly characteristic of chronic
venous disease. Stasis contributes to explain red blood
cell extravasation with consequent iron-laden macro-
phages and perivenous iron depositions.
Due to perivenular pattern of focal MS lesions, CCSVI
causes the stretching of endothelial tight junctions, caus-
ing diapedesis and degradation of erythrocytes, which
results in iron deposition surrounding the veins in brain
parenchyma (55). Advanced MRI studies have shown
higher iron concentrations in the thalamus and basal
ganglia of MS patients, in a deposition pattern associated
with venous drainage roots (56). The high iron concen-
trations in MS lesions might be caused by iron release
from the proteins to which it binds as a result of oligo-
dendrocyte destruction occurring during inflammation
and consequential lesion formation.
Cerebrospinal fluid dynamics and
venous hemodynamics
The cerebrospinal fluid (CSF) if formed in lateral
ventricles and mainly flows through brain’s ventricular
system, over and around cerebral hemisheres, and is
absorbed by arachnoid villi into the superior sagittal
sinus. Normal circulation of the CSF desires an optimal
balance between ultrafiltration of CSF and its clearance
from CSF spaces into the venous system at the level of
dural sinuses, which depands mainly on efficient venous
drainage (57, 58). A blinded MR pilot study demon-
strated venous outflow disturbance in MS patients (59).
Subjects with CCSVI showed higher frequency of ve-
nous reflux, blocked flow, B-mode abnormalities, and
reduced IJV compliance which led to increased VHISS
(54) (Venous Hemodynamic Insufficiency Severity Score)
and lower net cerebrospinal fluid CSF flow. The study
showed that impaired CSF dynamics may be a factor
contributing to the increased volumes in 3rd and lateral
ventricles, which was frequently observed in MS patients.
Authors demonstrated that CCSVI has a significant im-
pact on brain pathophysiology, especially on intracranial
fluid balance.
We cannot deny that CSF flow, and symptoms of MS
show a relationship to CCSVI, so we present several
symptoms of MS, studied by scientists who have proven a
vascular background to the problem.
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Optic neuritis: A study of retinal blood vessels and
their integrity (60) showed that more than half of patients
with optic neuritis, who had vascular abnormalities, de-
veloped MS, in comparison to those without vascular
abnormalities.
Transverse myelitis: It is considered also related to
MS. It occurs more often in occupations linked to Valsal-
va maneuver causing many pressure changers, and oc-
curring in everyday life, depending on professional phy-
sical demands (61).
Idiopathic intracranial hypertension (IIH): MS pa-
tients are found to have IIH, a 3D MR venography
(MRV) study showed 90% of MS patients to have sino-
venous stenosis (62). It is not clear whether these stenoses
are caused by the hypertension, or it is the other way
around (63, 64). What is the link between IIH and MS?
Is one causing the other, or is IIH coincidentally found in
individuals with MS? Russian literature seems to com-
monly accept the association of raised intracranial pres-
sure in the setting of MS exacerbations (65).
Hydrocephalus: CSF has an important role in regu-
lation of cerebral volume, by responding to incoming
arterial flow and outgoing venous flow. Considering that
about 70% of cerebral blood is venous blood, it is not
surprising that veins play an important role in system
compliance (66). There is evidence of venous compres-
sion in patients with communicating hydrocephalus. This
finding could relate to loss of visibility of medullary veins
in more severe cases (as seen by susceptibility weighted
imaging) (67). Recently, venous insufficiency has been
linked to hydrocephalus (68). References show an asso-
ciation of hydrocephalus with intracranial venous occlu-
sion, jugular venous obstruction, superior vena cava hy-
pertension and superior vena cava occlusion. Also, it has
been shown that hydrocephalus caused by jugular ste-
nosis is reversible (69).
We analyzed all the arguments against CCSVI as a
medical entity, and it’s association with MS. We revised
all the findings suggesting a possible connection between
these two entities. After careful review of all obtained
data we can conclude that great variability in prevalence
of the syndrome in MS patients can be a result of dif-
ferent methodologies used in vein assessment, training,
application of unapproved diagnostic criteria, or diffe-
rent approach to the problem itself. However, all obtain-
ed data point towards a need for further investigation of
this syndrome in MS as well as other demyelinating and
neurodegenerative diseases.
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